Valuation: Manhattan Scientifics, Inc.

Market Cap 336K 292K 272K 249K 471K 32.03M 478K 3.2M 1.26M 15.95M 1.26M 1.23M 53.48M P/E 2022
-1.64x
P/E 2023 -1.25x
Enterprise Value 329K 286K 266K 244K 461K 31.37M 468K 3.13M 1.23M 15.61M 1.23M 1.21M 52.36M EV / Sales 2022
88,184,960x
EV / Sales 2023 -
Free-Float
100%
Yield 2022 *
-
Yield 2023 -
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0.01
5 years 0
Extreme 0
0.03
10 years 0
Extreme 0
0.06
Manager TitleAgeSince
Chief Executive Officer 74 2007-10-31
President 89 1997-12-31
Director TitleAgeSince
Chairman 89 -
Chairman 74 2007-10-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 559
-2.16%+1.11%+38.84%+57.64% 610M
-3.14%+1.03%+14.84%-0.34% 391M
-2.04%+4.93%-20.06%-19.94% 93.24M
0.00%+0.98%-23.70%0.00% 50.37M
Average -1.47%+3.21%+2.48%+9.34% 228.77M
Weighted average by Cap. -2.39%+3.16%+23.09%+28.97%

Financials

2022 2023
Net sales 0.05 0.04 0.04 0.04 0.07 4.77 0.07 0.48 0.19 2.38 0.19 0.18 7.97 -
Net income -2.73M -2.37M -2.21M -2.03M -3.83M -261M -3.89M -26.04M -10.22M -130M -10.25M -10.03M -435M -1.16M -1.01M -943K -865K -1.63M -111M -1.66M -11.11M -4.36M -55.37M -4.38M -4.28M -186M
Net Debt -65K -56.5K -52.59K -48.29K -91.19K -6.2M -92.6K -620K -243K -3.09M -244K -239K -10.36M -7K -6.09K -5.66K -5.2K -9.82K -668K -9.97K -66.76K -26.2K -333K -26.29K -25.71K -1.12M
Logo Manhattan Scientifics, Inc.
Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator. Its business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate; and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.
Employees
1
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. MHTX Stock